US20050182471A1 - Magnetically shielded conductor - Google Patents

Magnetically shielded conductor Download PDF

Info

Publication number
US20050182471A1
US20050182471A1 US11/085,415 US8541505A US2005182471A1 US 20050182471 A1 US20050182471 A1 US 20050182471A1 US 8541505 A US8541505 A US 8541505A US 2005182471 A1 US2005182471 A1 US 2005182471A1
Authority
US
United States
Prior art keywords
recited
magnetically shielded
conductor assembly
conductor
shielded conductor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/085,415
Inventor
Xingwu Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biophan Technologies Inc
Original Assignee
Nanoset LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanoset LLC filed Critical Nanoset LLC
Priority to US11/085,415 priority Critical patent/US20050182471A1/en
Assigned to NANOSET, LLC reassignment NANOSET, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WANG, XINGWU
Publication of US20050182471A1 publication Critical patent/US20050182471A1/en
Assigned to BIOPHAN TECHNOLOGIES, INC. reassignment BIOPHAN TECHNOLOGIES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NANOSET, LLC
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/37Monitoring; Protecting
    • A61N1/3718Monitoring of or protection against external electromagnetic fields or currents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y25/00Nanomagnetism, e.g. magnetoimpedance, anisotropic magnetoresistance, giant magnetoresistance or tunneling magnetoresistance
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01BCABLES; CONDUCTORS; INSULATORS; SELECTION OF MATERIALS FOR THEIR CONDUCTIVE, INSULATING OR DIELECTRIC PROPERTIES
    • H01B11/00Communication cables or conductors
    • H01B11/02Cables with twisted pairs or quads
    • H01B11/06Cables with twisted pairs or quads with means for reducing effects of electromagnetic or electrostatic disturbances, e.g. screens
    • H01B11/10Screens specially adapted for reducing interference from external sources
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01BCABLES; CONDUCTORS; INSULATORS; SELECTION OF MATERIALS FOR THEIR CONDUCTIVE, INSULATING OR DIELECTRIC PROPERTIES
    • H01B11/00Communication cables or conductors
    • H01B11/02Cables with twisted pairs or quads
    • H01B11/06Cables with twisted pairs or quads with means for reducing effects of electromagnetic or electrostatic disturbances, e.g. screens
    • H01B11/10Screens specially adapted for reducing interference from external sources
    • H01B11/1058Screens specially adapted for reducing interference from external sources using a coating, e.g. a loaded polymer, ink or print
    • H01B11/1083Screens specially adapted for reducing interference from external sources using a coating, e.g. a loaded polymer, ink or print the coating containing magnetic material
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01FMAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F1/00Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
    • H01F1/0036Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties showing low dimensional magnetism, i.e. spin rearrangements due to a restriction of dimensions, e.g. showing giant magnetoresistivity
    • H01F1/0045Zero dimensional, e.g. nanoparticles, soft nanoparticles for medical/biological use
    • H01F1/0063Zero dimensional, e.g. nanoparticles, soft nanoparticles for medical/biological use in a non-magnetic matrix, e.g. granular solids
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01FMAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F10/00Thin magnetic films, e.g. of one-domain structure
    • H01F10/007Thin magnetic films, e.g. of one-domain structure ultrathin or granular films
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01FMAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F10/00Thin magnetic films, e.g. of one-domain structure
    • H01F10/32Spin-exchange-coupled multilayers, e.g. nanostructured superlattices
    • H01F10/324Exchange coupling of magnetic film pairs via a very thin non-magnetic spacer, e.g. by exchange with conduction electrons of the spacer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/08Arrangements or circuits for monitoring, protecting, controlling or indicating
    • A61N1/086Magnetic resonance imaging [MRI] compatible leads

Definitions

  • a conductor assembly comprised of a conductor disposed within an insulating sheath, wherein the sheath is coated with nanomagnetic material and nanoelectrical material.
  • implantable devices such as implantable pulse generators (IPGs) and cardioverter/defibrillator/pacemaker (CDPs), are sensitive to a variety of forms of electromagnetic interference (EMI). These devices include sensing and logic systems that respond to low-level signals from the heart. Because the sensing systems and conductive elements of these implantable devices are responsive to changes in local electromagnetic fields, they are vulnerable to external sources of severe electromagnetic noise, and in particular to electromagnetic fields emitted during magnetic resonance imaging (MRI) procedures. Therefore, patients with implantable devices are generally advised not to undergo magnetic resonance imaging (MRI) procedures, which often generate magnetic fields of from between about 1 about 20 Teslas.
  • MRI magnetic resonance imaging
  • a magnetically shielded conductor assembly comprised of a conductor disposed within an insulating matrix, wherein said insulating matrix is coated with a nanomagnetic particulate material.
  • FIG. 1 is a schematic sectional view of a shielded implanted device comprised of one preferred conductor assembly of the invention
  • FIG. 1A is a flow diagram of a preferred process of the invention
  • FIG. 2 is an enlarged sectional view of a portion of the conductor assembly of FIG. 1 ;
  • FIG. 3 is a sectional view of another conductor assembly of this invention.
  • FIG. 4 is a schematic view of the conductor assembly of FIG. 2 ;
  • FIG. 5 is a sectional view of the conductor assembly of FIG. 2 ;
  • FIGS. 6A and 6B are side and end sectional views of another preferred conductor assembly of this invention.
  • FIGS. 7A and 7B are end and side sectional views of yet another preferred conductor assembly of this invention.
  • FIG. 8 is a schematic representation of a conductor assembly that is partially coated and partially uncoated.
  • FIG. 1 is a schematic sectional view of one preferred device 10 that, in one embodiment, is implanted in a living organism.
  • device 10 is comprised of a power source 12 , a first conductor 14 , a second conductor 16 , a first insulative shield 18 disposed about power source 12 , a second insulative shield 20 disposed about a load 22 , a third insulative shield 23 disposed about a first conductor 14 , and a second conductor 16 , and a multiplicity of nanomagnetic particles 24 disposed on said first insulative shield, said second insulative shield, and said third insulative shield.
  • the power source 12 is a battery 12 that is operatively connected to a controller 26 .
  • controller 26 is operatively connected to the load 22 and the switch 28 . Depending upon the information furnished to controller 26 , it may deliver no current, direct current, and/or current pulses to the load 22 .
  • the controller 26 and/or the wires 30 and 32 are shielded from magnetic radiation.
  • one or more connections between the controller 26 and the switch 28 and/or the load 22 are made by wireless means such as, e.g., telemetry means.
  • the power source 12 provides a source of alternating current. In another embodiment, the power source 12 in conjunction with the controller 26 provides pulsed direct current.
  • the load 22 may be any of the implanted devices known to those skilled in the art.
  • load 22 may be a pacemaker.
  • load 22 may be an artificial heart.
  • load 22 may be a heart-massaging device.
  • load 22 may be a defibrillator.
  • the conductors 14 and 16 may be any conductive material(s) that have a resistivity at 20 degrees Centigrade of from about 1 to about 100 microohm-centimeters.
  • the conductive material(s) may be silver, copper, aluminum, alloys thereof, mixtures thereof, and the like.
  • the conductors 14 and 16 consist essentially of such conductive material.
  • step 40 the conductive wires 14 and 16 are coated with electrically insulative material.
  • Suitable insulative materials include nano-sized silicon dioxide, aluminum oxide, cerium oxide, yttrium-stabilized zirconia, silicon carbide, silicon nitride, aluminum nitride, and the like. In general, these nano-sized particles will have a particle size distribution such that at least about 90 weight percent of the particles have a maximum dimension in the range of from about 10 to about 100 nanometers.
  • the coated conductors 14 and 16 may be prepared by conventional means such as, e.g., the process described in U.S. Pat. No. 5,540,959, the entire disclosure of which is hereby incorporated by reference into this specification.
  • This patent describes and claims a process for preparing a coated substrate, comprising the steps of: (a) creating mist particles from a liquid, wherein: 1. said liquid is selected from the group consisting of a solution, a slurry, and mixtures thereof, 2. said liquid is comprised of solvent and from 0.1 to 75 grams of solid material per liter of solvent, 3. at least 95 volume percent of said mist particles have a maximum dimension less than 100 microns, and 4.
  • said mist particles are created from said first liquid at a rate of from 0.1 to 30 milliliters of liquid per minute; (b) contacting said mist particles with a carrier gas at a pressure of from 761 to 810 millimeters of mercury; (c) thereafter contacting said mist particles with alternating current radio frequency energy with a frequency of at least 1 megahertz and a power of at least 3 kilowatts while heating said mist particles to a temperature of at least about 100 degrees centigrade, thereby producing a heated vapor; (d) depositing said heated vapor onto a substrate, thereby producing a coated substrate; and (e) subjecting said coated substrate to a temperature of from about 450 to about 1,400 degrees centigrade for at least about 10 minutes.
  • conductors 14 and 16 may be coated by means of the processes disclosed in a text by D. Satas on “Coatings Technology Handbook” (Marcel Dekker, Inc., New York, N.Y., 1991). As is disclosed in such text, one may use cathodic arc plasma deposition (see pages 229 et seq.), chemical vapor deposition (see pages 257 et seq.), sol-gel coatings (see pages 655 et seq.), and the like.
  • FIG. 2 is a sectional view of the coated conductors 14 / 16 of the device of FIG. 1 .
  • conductors 14 and 16 are separated by insulating material 42 .
  • the insulating material 42 that is disposed between conductors 14 / 16 may be the same as the insulating material 44 / 46 that is disposed above conductor 14 and below conductor 16 .
  • the insulating material 42 may be different from the insulating material 44 and/or the insulating material 46 .
  • step 48 of the process describes disposing insulating material between the coated conductors 14 and 16 . This step may be done simultaneously with step 40 ; and it may be done thereafter.
  • the insulating material 42 , the insulating material 44 , and the insulating material 46 each generally has a resistivity of from about 1 ⁇ 10 9 to about 1 ⁇ 10 13 ohm-centimeters.
  • the coated conductor assembly is preferably heat treated in step 50 .
  • This heat treatment often is used in conjunction with coating processes in which the heat is required to bond the insulative material to the conductors 14 / 16 .
  • the heat-treatment step may be conducted after the deposition of the insulating material 42 / 44 / 46 , or it may be conducted simultaneously therewith. In either event, and when it is used, it is preferred to heat the coated conductors 14 / 16 to a temperature of from about 200 to about 600 degrees Centigrade for from about 1 minute to about 10 minutes.
  • step 52 of the process after the coated conductors 14 / 16 have been subjected to heat treatment step 50 , they are allowed to cool to a temperature of from about 30 to about 100 degrees Centigrade over a period of time of from about 3 to about 15 minutes.
  • nanomagnetic materials are coated onto the previously coated conductors 14 and 16 . This is best shown in FIG. 2 , wherein the nanomagnetic particles are identified as particles 24 .
  • nanomagnetic material is magnetic material which has an average particle size less than 100 nanometers and, preferably, in the range of from about 2 to 50 nanometers. Reference may be had, e.g., to U.S. Pat. No. 5,889,091 (rotationally free nanomagnetic material), U.S. Pat. Nos. 5,714,536, 5,667,924, and the like. The entire disclosure of each of these United States patents is hereby incorporated by reference into this specification.
  • the nanomagnetic materials may be, e.g., nano-sized ferrites such as, e.g., the nanomagnetic ferrites disclosed in U.S. Pat. No. 5,213,851, the entire disclosure of which is hereby incorporated by reference into this specification.
  • This patent claims a process for coating a layer of ferritic material with a thickness of from about 0.1 to about 500 microns onto a substrate at a deposition rate of from about 0.01 to about 10 microns per minute per 35 square centimeters of substrate surface, comprising the steps of: (a) providing a solution comprised of a first compound and a second compound, wherein said first compound is an iron compound and said second compound is selected from the group consisting of compounds of nickel, zinc, magnesium, strontium, barium, manganese, lithium, lanthanum, yttrium, scandium, samarium, europium, terbium, dysprosium, holmium, erbium, ytterbium, lutetium, cerium, praseodymium, thulium, neodymium, gadolinium, aluminum, iridium, lead, chromium, gallium, indium, chromium, samarium, cobalt, titanium, and
  • the thickness of the layer of nanomagnetic material deposited onto the coated conductors 14 / 16 is less than about 5 microns and generally from about 0.1 to about 3 microns.
  • the coated assembly may be optionally heat-treated in step 56 .
  • this optional step 56 it is preferred to subject the coated conductors 14 / 16 to a temperature of from about 200 to about 600 degrees Centigrade for from about I to about 10 minutes.
  • one or more additional insulating layers 43 are coated onto the assembly depicted in FIG. 2 , by one or more of the processes disclosed hereinabove. This is conducted in optional step 58 (see FIG. IA).
  • FIG. 4 is a partial schematic view of the assembly 11 of FIG. 2 , illustrating the current flow in such assembly. Referring go FIG. 4 , it will be seen that current flows into conductor 14 in the direction of arrow 60 , and it flows out of conductor 16 in the direction of arrow 62 . The net current flow through the assembly 11 is zero; and the net Lorentz force in the assembly 11 is thus zero. Consequently, even high current flows in the assembly 11 do not cause such assembly to move.
  • conductors 14 and 16 are substantially parallel to each other. As will be apparent, without such parallel orientation, there may be some net current and some net Lorentz effect.
  • the conductors 14 and 16 preferably have the same diameters and/or the same compositions and/or the same length.
  • the nanomagnetic particles 24 are present in a density sufficient so as to provide shielding from magnetic flux lines 64 . Without wishing to be bound to any particular theory, applicant believes that the nanomagnetic particles 24 trap and pin the magnetic lines of flux 64 .
  • the nanomagnetic particles 24 have a specified magnetization.
  • magnetization is the magnetic moment per unit volume of a substance. Reference may be had, e.g., to U.S. Pat. Nos. 4,169,998, 4,168,481, 4,166,263, 5,260,132, 4,778,714, and the like. The entire disclosure of each of these United States patents is hereby incorporated by reference into this specification.
  • the layer of nanomagnetic particles 24 preferably has a saturation magnetization, at 25 degrees Centigrade, of from about 200 to about 25,000 Gauss, or higher.
  • the saturation magnetization at room temperature of the nanomagnetic particles is from about 500 to about 10,000 Gauss.
  • a thin film with a thickness of less than about 2 microns and a saturation magnetization in excess of 20,000 Gauss.
  • the thickness of the layer of nanomagnetic material is measured from the bottom surface of the layer that contains such material to the top surface of such layer that contains such material; and such bottom surface and/or such top surface may be contiguous with other layers of material (such as insulating material) that do not contain nanomagnetic particles.
  • a saturation magnetization of 24,000 Gauss By the appropriate selection of nanomagnetic particles, and the thickness of the films deposited, one may obtain saturation magnetizations of as high as at least about 26,000.
  • the nanomagnetic particles 24 are disposed within an insulating matrix so that any heat produced by such particles will be slowly dispersed within such matrix.
  • Such matrix may be made from ceria, calcium oxide, silica, alumina.
  • the insulating material 42 preferably has a thermal conductivity of less than about 20 (calories centimeters/square centimeters-degree second) ⁇ 10,000. See, e.g., page E-6 of the 63 rd Edition of the “Handbook of Chemistry and Physics” (CRC Press, Inc., Boca Raton, Fla., 1982).
  • the nanomagnetic materials 24 typically comprise one or more of iron, cobalt, nickel, gadolinium, and samarium atoms.
  • typical nanomagnetic materials include alloys of iron and nickel (permalloy), cobalt, niobium, and zirconium (CNZ), iron, boron, and nitrogen, cobalt, iron, boron, and silica, iron, cobalt, boron, and fluoride, and the like.
  • FIG. 5 is a sectional view of the assembly 11 of FIG. 2 .
  • the device of FIG. 5 and of the other Figures of this application, is preferably substantially flexible.
  • the term flexible refers to an assembly that can be bent to form a circle with a radius of less than 2 centimeters without breaking. Put another way, the bend radius of the coated assembly 11 can be less than 2 centimeters.
  • FIGS. 6A and 6B are side and end sectional views of another preferred conductor assembly 101 of this invention.
  • the assembly 101 is similar in configuration to the assembly 11 but differs therefrom in that only one conductor 14 is utilized. Disposed around conductor 14 are a layer of insulating material 44 , a layer of nanoelectrical material 102 , and a layer of nanomagnetic material 100 .
  • the layer of nanoelectrical material 102 preferably has a thickness of from about 0.5 to about 2 microns.
  • the nanoelectrical material comprising layer 102 has a resistivity of from about 1.6 to about 100 microohm-centimeters.
  • WO9820719 in which reference is made to U.S. Pat. No. 4,963,291; each of these patents and patent applications is hereby incorporated by reference into this specification.
  • the nanoelectrical particles used in this invention preferably have a particle size within the range of from about I to about 100 microns, and a resistivity of from about 1.6 to about 100 microohm-centimeters.
  • such nanoelectrical particles comprise a mixture of iron and aluminum.
  • such nanoelectrical particles consist essentially of a mixture of iron and aluminum. It is preferred that, in such nanoelectrical particles, and in one embodiment, at least 9 moles of aluminum are present for each mole of iron. In another embodiment, at least about 9.5 moles of aluminum are present for each mole of iron. In yet another embodiment, at least 9.9 moles of aluminum are present for each mole of iron.
  • FIGS. 7A and 7B are end and side sectional views of conductor assembly 120 that is similar to the assembly 101 (see FIGS. 6A and 6B ) but differs therefrom in that the nanoelectrical material and the nanomagnetic material are both disposed in the same layer 105 .
  • FIG. 8 is schematic representation of a coated conductor assembly 130 comprised of flexible conductor 14 and coating 105 .
  • the coating 105 contains both nanomagnetic and nanoelectrical particles. In another embodiment, not shown, the coating 105 contains only nanomagnetic particles.
  • sections 134 , 134 , and 136 , and 138 are not coated with the coating 105 .
  • the uncoated sections 134 et seq. are less likely to increase their temperature upon being exposed to electromagnetic radiation and, thus, can more readily be contacted with the tissue of a biological organism.

Abstract

A magnetically shielded conductor assembly containing a conductor disposed within an insulating matrix, and nanomagnetic material and nanoelectrical material disposed around the conductor. The conductor has a resistivity at 20 degrees Centigrade of from about 1 to about 100 microohm-centimeters. The insulating matrix is composed of nano-sized particles having a maximum dimension of from about 10 to about 100 nanometers. The insulating matrix has a resistivity of from about 1×109 to about 1×10 13 ohm-centimeter. The nanomagnetic material has an average particle size of less than about 100 nanometers. The nanomagnetic material has a saturation magnetization of from about 200 to about 26,000 Gauss. The magnetically shielded conductor assembly is flexible, having a bend radius of less than 2 centimeters.

Description

    CROSS-REFERENCE TO RELATED PATENT APPLICATIONS
  • This application is a continuation of applicant's co-pending patent application, U.S. Ser. No. 10/229,183, filed on Aug. 26, 2002, which is a continuation-in-part of U.S. Ser. No. 10/054,407, filed on Jan. 22, 2002. The entire content of each of the above patent applications is hereby incorporated by reference into this specification.
  • FIELD OF THE INVENTION
  • A conductor assembly comprised of a conductor disposed within an insulating sheath, wherein the sheath is coated with nanomagnetic material and nanoelectrical material.
  • BACKGROUND OF THE INVENTION
  • Many implanted medical devices that are powered by electrical energy have been developed. Most of these devices comprise a power source, one or more conductors, and a load.
  • When a patient with one of these implanted devices is subjected to high intensity magnetic fields, currents are often induced in the implanted conductors. The large current flows so induced often create substantial amounts of heat. Because living organisms can generally only survive within a relatively narrow range of temperatures, these large current flows are dangerous.
  • Furthermore, implantable devices, such as implantable pulse generators (IPGs) and cardioverter/defibrillator/pacemaker (CDPs), are sensitive to a variety of forms of electromagnetic interference (EMI). These devices include sensing and logic systems that respond to low-level signals from the heart. Because the sensing systems and conductive elements of these implantable devices are responsive to changes in local electromagnetic fields, they are vulnerable to external sources of severe electromagnetic noise, and in particular to electromagnetic fields emitted during magnetic resonance imaging (MRI) procedures. Therefore, patients with implantable devices are generally advised not to undergo magnetic resonance imaging (MRI) procedures, which often generate magnetic fields of from between about 1 about 20 Teslas.
  • One additional problem with implanted conductors is that, when they are conducting electricity and are simultaneously subjected to large magnetic fields, a Lorentz force is created which often causes the conductor to move. This movement may damage body tissue.
  • In U.S. Pat. No. 4,180,600, there is disclosed and claimed a fine magnetically shielded conductor wire consisting of a conductive copper core and a magnetically soft alloy metallic sheath metallurgically secured to the conductive core, wherein the sheath consists essentially of from 2 to 5 weight percent of molybdenum, from about 15 to about 23 weight percent of iron, and from about 75 to about 85 weight percent of nickel. Although the device of this patent does provide magnetic shielding, it still creates heat when it interacts with strong magnetic fields.
  • It is an object of this invention to provide a conductor assembly, which is shielded from large magnetic fields, which does not create large amounts of heat in the presence of such fields, and which does not exhibit the Lorentz effect when subjected to such fields.
  • SUMMARY OF THE INVENTION
  • In accordance with this invention, there is provided a magnetically shielded conductor assembly comprised of a conductor disposed within an insulating matrix, wherein said insulating matrix is coated with a nanomagnetic particulate material.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The invention will be described by reference to the following drawings, in which like numerals refer to like elements, and in which:
  • FIG. 1 is a schematic sectional view of a shielded implanted device comprised of one preferred conductor assembly of the invention;
  • FIG. 1A is a flow diagram of a preferred process of the invention;
  • FIG. 2 is an enlarged sectional view of a portion of the conductor assembly of FIG. 1;
  • FIG. 3 is a sectional view of another conductor assembly of this invention;
  • FIG. 4 is a schematic view of the conductor assembly of FIG. 2;
  • FIG. 5 is a sectional view of the conductor assembly of FIG. 2;
  • FIGS. 6A and 6B are side and end sectional views of another preferred conductor assembly of this invention;
  • FIGS. 7A and 7B are end and side sectional views of yet another preferred conductor assembly of this invention; and
  • FIG. 8 is a schematic representation of a conductor assembly that is partially coated and partially uncoated.
  • DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • FIG. 1 is a schematic sectional view of one preferred device 10 that, in one embodiment, is implanted in a living organism. Referring to FIG. 1, it will be seen that device 10 is comprised of a power source 12, a first conductor 14, a second conductor 16, a first insulative shield 18 disposed about power source 12, a second insulative shield 20 disposed about a load 22, a third insulative shield 23 disposed about a first conductor 14, and a second conductor 16, and a multiplicity of nanomagnetic particles 24 disposed on said first insulative shield, said second insulative shield, and said third insulative shield.
  • In the embodiment depicted in FIG. 1, the power source 12 is a battery 12 that is operatively connected to a controller 26. In the embodiment depicted, controller 26 is operatively connected to the load 22 and the switch 28. Depending upon the information furnished to controller 26, it may deliver no current, direct current, and/or current pulses to the load 22.
  • In one embodiment, not shown, the controller 26 and/or the wires 30 and 32 are shielded from magnetic radiation. In another embodiment, not shown, one or more connections between the controller 26 and the switch 28 and/or the load 22 are made by wireless means such as, e.g., telemetry means.
  • In one embodiment, not shown, the power source 12 provides a source of alternating current. In another embodiment, the power source 12 in conjunction with the controller 26 provides pulsed direct current.
  • The load 22 may be any of the implanted devices known to those skilled in the art. Thus, e.g., load 22 may be a pacemaker. Thus, e.g., load 22 may be an artificial heart. Thus, e.g., load 22 may be a heart-massaging device. Thus, e.g., load 22 may be a defibrillator.
  • The conductors 14 and 16 may be any conductive material(s) that have a resistivity at 20 degrees Centigrade of from about 1 to about 100 microohm-centimeters. Thus, e.g., the conductive material(s) may be silver, copper, aluminum, alloys thereof, mixtures thereof, and the like. In one embodiment, the conductors 14 and 16 consist essentially of such conductive material. Thus, e.g., it is preferred not to use, e.g., copper wire coated with enamel. The use of such typical enamel coating on the conductor does not work well in the instant invention.
  • In the first step of the process of this invention, step 40, the conductive wires 14 and 16 are coated with electrically insulative material. Suitable insulative materials include nano-sized silicon dioxide, aluminum oxide, cerium oxide, yttrium-stabilized zirconia, silicon carbide, silicon nitride, aluminum nitride, and the like. In general, these nano-sized particles will have a particle size distribution such that at least about 90 weight percent of the particles have a maximum dimension in the range of from about 10 to about 100 nanometers.
  • The coated conductors 14 and 16 may be prepared by conventional means such as, e.g., the process described in U.S. Pat. No. 5,540,959, the entire disclosure of which is hereby incorporated by reference into this specification. This patent describes and claims a process for preparing a coated substrate, comprising the steps of: (a) creating mist particles from a liquid, wherein: 1. said liquid is selected from the group consisting of a solution, a slurry, and mixtures thereof, 2. said liquid is comprised of solvent and from 0.1 to 75 grams of solid material per liter of solvent, 3. at least 95 volume percent of said mist particles have a maximum dimension less than 100 microns, and 4. said mist particles are created from said first liquid at a rate of from 0.1 to 30 milliliters of liquid per minute; (b) contacting said mist particles with a carrier gas at a pressure of from 761 to 810 millimeters of mercury; (c) thereafter contacting said mist particles with alternating current radio frequency energy with a frequency of at least 1 megahertz and a power of at least 3 kilowatts while heating said mist particles to a temperature of at least about 100 degrees centigrade, thereby producing a heated vapor; (d) depositing said heated vapor onto a substrate, thereby producing a coated substrate; and (e) subjecting said coated substrate to a temperature of from about 450 to about 1,400 degrees centigrade for at least about 10 minutes.
  • By way of further illustration, one may coat conductors 14 and 16 by means of the processes disclosed in a text by D. Satas on “Coatings Technology Handbook” (Marcel Dekker, Inc., New York, N.Y., 1991). As is disclosed in such text, one may use cathodic arc plasma deposition (see pages 229 et seq.), chemical vapor deposition (see pages 257 et seq.), sol-gel coatings (see pages 655 et seq.), and the like.
  • FIG. 2 is a sectional view of the coated conductors 14/16 of the device of FIG. 1. Referring to FIG. 2, it will be seen that conductors 14 and 16 are separated by insulating material 42. In order to obtain the structure depicted in FIG. 2, one may simultaneously coat conductors 14 and 16 with the insulating material so that such insulators both coat the conductors 14 and 16 and fill in the distance between them with insulation.
  • The insulating material 42 that is disposed between conductors 14/16, may be the same as the insulating material 44/46 that is disposed above conductor 14 and below conductor 16. Alternatively, and as dictated by the choice of processing steps and materials, the insulating material 42 may be different from the insulating material 44 and/or the insulating material 46. Thus, step 48 of the process describes disposing insulating material between the coated conductors 14 and 16. This step may be done simultaneously with step 40; and it may be done thereafter. The insulating material 42, the insulating material 44, and the insulating material 46 each generally has a resistivity of from about 1×109 to about 1×1013 ohm-centimeters.
  • After the insulating material 42/44/46 has been deposited, and in one embodiment, the coated conductor assembly is preferably heat treated in step 50. This heat treatment often is used in conjunction with coating processes in which the heat is required to bond the insulative material to the conductors 14/16.
  • The heat-treatment step may be conducted after the deposition of the insulating material 42/44/46, or it may be conducted simultaneously therewith. In either event, and when it is used, it is preferred to heat the coated conductors 14/16 to a temperature of from about 200 to about 600 degrees Centigrade for from about 1 minute to about 10 minutes.
  • Referring again to FIG. 1A, and in step 52 of the process, after the coated conductors 14/16 have been subjected to heat treatment step 50, they are allowed to cool to a temperature of from about 30 to about 100 degrees Centigrade over a period of time of from about 3 to about 15 minutes.
  • One need not invariably heat treat and/or cool. Thus, referring to FIG. IA, one may immediately coat nanomagnetic particles onto to the coated conductors 14/16 in step 54 either after step 48 and/or after step 50 and/or after step 52.
  • In step 54, nanomagnetic materials are coated onto the previously coated conductors 14 and 16. This is best shown in FIG. 2, wherein the nanomagnetic particles are identified as particles 24. In general, and as is known to those skilled in the art, nanomagnetic material is magnetic material which has an average particle size less than 100 nanometers and, preferably, in the range of from about 2 to 50 nanometers. Reference may be had, e.g., to U.S. Pat. No. 5,889,091 (rotationally free nanomagnetic material), U.S. Pat. Nos. 5,714,536, 5,667,924, and the like. The entire disclosure of each of these United States patents is hereby incorporated by reference into this specification.
  • The nanomagnetic materials may be, e.g., nano-sized ferrites such as, e.g., the nanomagnetic ferrites disclosed in U.S. Pat. No. 5,213,851, the entire disclosure of which is hereby incorporated by reference into this specification. This patent claims a process for coating a layer of ferritic material with a thickness of from about 0.1 to about 500 microns onto a substrate at a deposition rate of from about 0.01 to about 10 microns per minute per 35 square centimeters of substrate surface, comprising the steps of: (a) providing a solution comprised of a first compound and a second compound, wherein said first compound is an iron compound and said second compound is selected from the group consisting of compounds of nickel, zinc, magnesium, strontium, barium, manganese, lithium, lanthanum, yttrium, scandium, samarium, europium, terbium, dysprosium, holmium, erbium, ytterbium, lutetium, cerium, praseodymium, thulium, neodymium, gadolinium, aluminum, iridium, lead, chromium, gallium, indium, chromium, samarium, cobalt, titanium, and mixtures thereof, and wherein said solution is comprised of from about 0.01 to about 1,000 grams of a mixture consisting essentially of said compounds per liter of said solution; (b) subjecting said solution to ultrasonic sound waves at a frequency in excess of 20,000 hertz, and to an atmospheric pressure of at least about 600 millimeters of mercury, thereby causing said solution to form into an aerosol; (c) providing a radio frequency plasma reactor comprised of a top section, a bottom section, and a radio-frequency coil; (d) generating a hot plasma gas within said radio frequency plasma reactor, thereby producing a plasma region; (e) providing a flame region disposed above said top section of said radio frequency plasma reactor; (f) contacting said aerosol with said hot plasma gas within said plasma reactor while subjecting said aerosol to an atmospheric pressure of at least about 600 millimeters of mercury and to a radio frequency alternating current at a frequency of from about 100 kilohertz to about 30 megahertz, thereby forming a vapor; (g) providing a substrate disposed above said flame region; and (h) contacting said vapor with said substrate, thereby forming said layer of ferritic material.
  • By way of further illustration, one may use the techniques described in an article by M. De Marco, X. W. Wang, et al. on “Mossbauer and magnetization studies of nickel ferrites” published in the Journal of Applied Physics 73(10), May 15, 1993, at pages 6287-6289.
  • In general, the thickness of the layer of nanomagnetic material deposited onto the coated conductors 14/16 is less than about 5 microns and generally from about 0.1 to about 3 microns.
  • After the nanomagnetic material is coated in step 54, the coated assembly may be optionally heat-treated in step 56. In this optional step 56, it is preferred to subject the coated conductors 14/16 to a temperature of from about 200 to about 600 degrees Centigrade for from about I to about 10 minutes. In one embodiment, illustrated in FIG. 3, one or more additional insulating layers 43 are coated onto the assembly depicted in FIG. 2, by one or more of the processes disclosed hereinabove. This is conducted in optional step 58 (see FIG. IA).
  • FIG. 4 is a partial schematic view of the assembly 11 of FIG. 2, illustrating the current flow in such assembly. Referring go FIG. 4, it will be seen that current flows into conductor 14 in the direction of arrow 60, and it flows out of conductor 16 in the direction of arrow 62. The net current flow through the assembly 11 is zero; and the net Lorentz force in the assembly 11 is thus zero. Consequently, even high current flows in the assembly 11 do not cause such assembly to move.
  • In the embodiment depicted in FIG. 4, conductors 14 and 16 are substantially parallel to each other. As will be apparent, without such parallel orientation, there may be some net current and some net Lorentz effect.
  • In the embodiment depicted in FIG. 4, and in one preferred aspect thereof, the conductors 14 and 16 preferably have the same diameters and/or the same compositions and/or the same length.
  • Referring again to FIG. 4, the nanomagnetic particles 24 are present in a density sufficient so as to provide shielding from magnetic flux lines 64. Without wishing to be bound to any particular theory, applicant believes that the nanomagnetic particles 24 trap and pin the magnetic lines of flux 64.
  • In order to function optimally, the nanomagnetic particles 24 have a specified magnetization. As is known to those skilled in the art, magnetization is the magnetic moment per unit volume of a substance. Reference may be had, e.g., to U.S. Pat. Nos. 4,169,998, 4,168,481, 4,166,263, 5,260,132, 4,778,714, and the like. The entire disclosure of each of these United States patents is hereby incorporated by reference into this specification.
  • Referring again to FIG. 4, the layer of nanomagnetic particles 24 preferably has a saturation magnetization, at 25 degrees Centigrade, of from about 200 to about 25,000 Gauss, or higher. In one embodiment, the saturation magnetization at room temperature of the nanomagnetic particles is from about 500 to about 10,000 Gauss. For a discussion of the saturation magnetization of various materials, reference may be had, e.g., to U.S. Pat. Nos. 4,705,613, 4,631,613, 5,543,070, 3,901,741 (cobalt, samarium, and gadolinium alloys), and the like. The entire disclosure of each of these United States patents is hereby incorporated by reference into this specification. As will be apparent to those skilled in the art, especially upon studying the aforementioned patents, the saturation magnetization of thin films is often higher than the saturation magnetization of bulk objects.
  • In one embodiment, it is preferred to utilize a thin film with a thickness of less than about 2 microns and a saturation magnetization in excess of 20,000 Gauss. The thickness of the layer of nanomagnetic material is measured from the bottom surface of the layer that contains such material to the top surface of such layer that contains such material; and such bottom surface and/or such top surface may be contiguous with other layers of material (such as insulating material) that do not contain nanomagnetic particles.
  • Thus, e.g., one may make a thin film in accordance with the procedure described at page 156 of Nature, Volume 407, Sep. 14, 2000, that describes a multilayer thin film has a saturation magnetization of 24,000 Gauss. By the appropriate selection of nanomagnetic particles, and the thickness of the films deposited, one may obtain saturation magnetizations of as high as at least about 26,000.
  • In the preferred embodiment depicted in FIG. 4, the nanomagnetic particles 24 are disposed within an insulating matrix so that any heat produced by such particles will be slowly dispersed within such matrix. Such matrix, as indicated hereinabove, may be made from ceria, calcium oxide, silica, alumina. In general, the insulating material 42 preferably has a thermal conductivity of less than about 20 (calories centimeters/square centimeters-degree second)×10,000. See, e.g., page E-6 of the 63rd Edition of the “Handbook of Chemistry and Physics” (CRC Press, Inc., Boca Raton, Fla., 1982).
  • The nanomagnetic materials 24 typically comprise one or more of iron, cobalt, nickel, gadolinium, and samarium atoms. Thus, e.g., typical nanomagnetic materials include alloys of iron and nickel (permalloy), cobalt, niobium, and zirconium (CNZ), iron, boron, and nitrogen, cobalt, iron, boron, and silica, iron, cobalt, boron, and fluoride, and the like. These and other materials are descried in a book by J. Douglas Adam et al. entitled “Handbook of Thin Film Devices” (Academic Press, San Diego, Calif., 2000). Chapter 5 of this book beginning at page 185, describes “magnetic films for planar inductive components and devices;” and Tables 5.1 and 5.2 in this chapter describe many magnetic materials.
  • FIG. 5 is a sectional view of the assembly 11 of FIG. 2. The device of FIG. 5, and of the other Figures of this application, is preferably substantially flexible. As used in this specification, the term flexible refers to an assembly that can be bent to form a circle with a radius of less than 2 centimeters without breaking. Put another way, the bend radius of the coated assembly 11 can be less than 2 centimeters. Reference may be had, e.g., to U.S. Pat. Nos. 4,705,353; 5,946,439; 5,315,365; 4,641,917; 5,913,005; and the like. The entire disclosure of each of these United States patents is hereby incorporated by reference into this specification.
  • As will be apparent, even when the magnetic insulating properties of the assembly of this invention are not 100 percent effective, the assembly still prevents the rapid dissipation of heat to bodily tissue.
  • FIGS. 6A and 6B are side and end sectional views of another preferred conductor assembly 101 of this invention. The assembly 101 is similar in configuration to the assembly 11 but differs therefrom in that only one conductor 14 is utilized. Disposed around conductor 14 are a layer of insulating material 44, a layer of nanoelectrical material 102, and a layer of nanomagnetic material 100.
  • The layer of nanoelectrical material 102 preferably has a thickness of from about 0.5 to about 2 microns. The nanoelectrical material comprising layer 102 has a resistivity of from about 1.6 to about 100 microohm-centimeters. As is known to those skilled in the art, when nanoelectrical material is exposed to electromagnetic radiation, and in particular to an electric field, it will shield the substrate over which it is disposed from such electrical field. Reference may be had, e.g., to International patent publication WO9820719 in which reference is made to U.S. Pat. No. 4,963,291; each of these patents and patent applications is hereby incorporated by reference into this specification.
  • As is disclosed in U.S. Pat. No. 4,963,291 of Bercaw, one may produce electromagnetic shielding resins comprised of electroconductive particles, such as iron, aluminum, copper, silver and steel in sizes ranging from 0.5 to 0.50 microns. The entire disclosure of this United States patent is hereby incorporated by reference into this specification.
  • The nanoelectrical particles used in this invention preferably have a particle size within the range of from about I to about 100 microns, and a resistivity of from about 1.6 to about 100 microohm-centimeters. In one embodiment, such nanoelectrical particles comprise a mixture of iron and aluminum. In another embodiment, such nanoelectrical particles consist essentially of a mixture of iron and aluminum. It is preferred that, in such nanoelectrical particles, and in one embodiment, at least 9 moles of aluminum are present for each mole of iron. In another embodiment, at least about 9.5 moles of aluminum are present for each mole of iron. In yet another embodiment, at least 9.9 moles of aluminum are present for each mole of iron.
  • FIGS. 7A and 7B are end and side sectional views of conductor assembly 120 that is similar to the assembly 101 (see FIGS. 6A and 6B) but differs therefrom in that the nanoelectrical material and the nanomagnetic material are both disposed in the same layer 105. One may produce such a layer 105 by simultaneously depositing the nanoelectrical particles and the nanomagnetic particles with, e.g., sputtering technology.
  • FIG. 8 is schematic representation of a coated conductor assembly 130 comprised of flexible conductor 14 and coating 105. In the embodiment depicted, the coating 105 contains both nanomagnetic and nanoelectrical particles. In another embodiment, not shown, the coating 105 contains only nanomagnetic particles.
  • Referring to FIG. 8, it will be seen that sections 134, 134, and 136, and 138 are not coated with the coating 105. The uncoated sections 134 et seq. are less likely to increase their temperature upon being exposed to electromagnetic radiation and, thus, can more readily be contacted with the tissue of a biological organism.
  • It is to be understood that the aforementioned description is illustrative only and that changes can be made in the apparatus, in the ingredients and their proportions, and in the sequence of combinations and process steps, as well as in other aspects of the invention discussed herein, without departing from the scope of the invention as defined in the following claims.
  • Thus, e.g., although one embodiment of the process of this invention has been illustrated with regard to two separate, non-contiguous conductors 14 and 16, such process will also function with two contiguous conductors.

Claims (44)

1. A magnetically shielded conductor assembly comprised of a
a. conductor wherein said conductor has a resistivity of from about 1 to about 100 microohm-centimeters;
b. an insulation shield disposed around said conductor wherein said insulation shield is comprised of an insulating material and electrically insulating particles wherein
1. at least about 90 weight percent of said electrically insulating particles have a maximum dimension of less than about 100 nanometers;
2. said insulation shield has a saturation magnetization at 25 degrees Centigrade of at least about 2,000 Gauss; and
3. said insulation shield has a resistivity of from about 1×109 to about 1×1013 ohm-centimeter.
2. The magnetically shielded conductor assembly as recited in claim 1, wherein said insulation shield has a saturation magnetization at 25 degrees Centigrade of at least about 10,000 Gauss.
3. The magnetically shielded conductor assembly as recited in claim 2, wherein said insulation shield has a saturation magnetization at 25 degrees Centigrade of at least about 26,000 Gauss.
4. The magnetically shielded conductor assembly as recited in claim 1, further comprising an electrical shield which is comprised of electrically conductive particles wherein
a. at least about 90 weight percent of said electrically conductive particles have a maximum dimension of less than about 100 microns;
b. said electrical shield has a resistivity of from about 1.6 to about 100 microohm-centimeters; and
c. said electrical shield is not contiguous with said conductor.
5. The magnetically shielded conductor assembly as recited in claim 4, further comprising a power source.
6. The magnetically shielded conductor assembly as recited in claim 5, further comprising a load and a controller wherein said power source is operatively connected to said controller and said controller is operatively connected to said load.
7. The magnetically shielded conductor assembly as recited in claim 6, wherein said controller is disposed within said insulation shield.
8. The magnetically shielded conductor assembly as recited in claim 7, wherein said power source supplies alternating current.
9. The magnetically shielded conductor assembly as recited in claim 7, wherein said power source supplies direct current.
10. The magnetically shielded conductor assembly as recited in claim 7, wherein said magnetically shielded conductor assembly is operatively configured to be implanted within a biological organism.
11. The magnetically shielded conductor assembly as recited in claim 10, wherein said load is selected from the group consisting of a pacemaker, an artificial heart, a heart-massaging device, and a defibrillator.
12. The magnetically shielded conductor assembly as recited in claim 4, wherein said insulating material is selected from the group consisting of silicon dioxide, aluminum oxide, cerium oxide, yttrium-stabilized zirconia, silica carbide, silicon nitride, aluminum nitride, and combinations thereof.
13. The magnetically shielded conductor assembly as recited in claim 4, wherein said at least about 90 weight percent of said electrically insulating particles and said electrically conductive particles have a maximum dimension of from about 2 to about 50 nanometers.
14. The magnetically shielded conductor assembly as recited in claim 4, wherein said conductor consists essentially of a conductive material selected from the group consisting of silver, copper, aluminum, alloys thereof, and mixtures thereof.
15. The magnetically shielded conductor assembly as recited in claim 4, further comprising a second conductor wherein said second conductor has a resistivity of from about 1 to about 100 microohm-centimeters and wherein said insulation shield disposed around said second conductor.
16. The magnetically shielded conductor assembly as recited in claim 15, wherein said conductor and said second conductor are substantially parallel to each other.
17. The magnetically shielded conductor assembly as recited in claim 15, further comprising an insulating matrix wherein said insulating matrix is disposed between said conductor and said second conductor.
18. The magnetically shielded conductor assembly as recited in claim 17, wherein said insulating matrix has a resistivity of from about 1×109 to about 1×1013 ohm-centimeters.
19. The magnetically shielded conductor assembly as recited in claim 18, wherein said insulating matrix consists essentially of said insulating material.
20. The magnetically shielded conductor assembly as recited in claim 4, wherein said electrically insulating particles are comprised of ferrites.
21. The magnetically shielded conductor assembly as recited in claim 4, wherein said insulation shield is a layer with a thickness of less than about 5 microns.
22. The magnetically shielded conductor assembly as recited in claim 21, wherein said insulation shield is a layer with a thickness of from about 0.1 microns to about 3 microns.
23. The magnetically shielded conductor assembly as recited in claim 22, wherein said electrical shield is a layer with a thickness of from about 0.1 microns to about 3 microns.
24. The magnetically shielded conductor assembly as recited in claim 4, wherein said insulating material has a thermal conductivity of less than about 200,000 calories centimeters per square centimeter degree seconds.
25. The magnetically shielded conductor assembly as recited in claim 24, wherein said magnetically shielded conductor assembly is flexible, having a bend radius of less than 2 centimeters.
26. A magnetically shielded conductor assembly comprised of a
a. a first conductor;
b. a second conductor wherein said first conductor and said second conductor are substantially parallel to one another;
c. an insulation shield disposed around said first conductor and said second doctor wherein said insulation shield is comprised electrically insulating particles wherein
1. at least about 90 weight percent of said electrically insulating particles have a maximum dimension of less than about 100 nanometers;
2. said insulation shield has a saturation magnetization at 25 degrees Centigrade of at least about 2,000 Gauss.
27. The magnetically shielded conductor assembly as recited in claim 23, wherein said insulation shield is further comprised of an insulating material.
28. The magnetically shielded conductor assembly as recited in claim 27, wherein said insulation shield has a saturation magnetization at 25 degrees Centigrade of at least about 10,000 Gauss.
29. The magnetically shielded conductor assembly as recited in claim 28, wherein said insulation shield has a saturation magnetization at 25 degrees Centigrade of at least about 26,000 Gauss.
30. The magnetically shielded conductor assembly as recited in claim 29, wherein said electrically conductive particles are selected from the group consisting of iron, aluminum, copper silver and steel.
31. The magnetically shielded conductor assembly as recited in claim 30, wherein at least about 90 weight percent of said electrically conductive particles have a maximum dimension of less than about 100 nanometers.
32. The magnetically shielded conductor assembly as recited in claim 31, wherein said electrically conductive particles are comprised of iron and aluminum.
33. The magnetically shielded conductor assembly as recited in claim 32, wherein said electrically conductive particles consist essentially of iron and aluminum.
34. The magnetically shielded conductor assembly as recited in claim 33, wherein the molar ratio of aluminum to iron at least about 9 to 1.
35. The magnetically shielded conductor assembly as recited in claim 33, wherein the molar ratio of aluminum to iron at least about 9.5 to 1.
36. The magnetically shielded conductor assembly as recited in claim 33, wherein the molar ratio of aluminum to iron at least about 9.9 to 1.
37. The magnetically shielded conductor assembly as recited in claim 36, wherein said electrically conducting particles and said electrically insulating particles are present in the same layer.
38. The magnetically shielded conductor assembly as recited in claim 36, wherein said electrically conducting particles and said electrically insulating particles are present in two separate layers.
39. The magnetically shielded conductor assembly as recited in claim 36, wherein said first conductor and said second conductor are contiguous with one another.
40. The magnetically shielded conductor assembly as recited in claim 36, wherein said first conductor and said second conductor are non-contiguous with one another.
41. A process for producing a magnetically shielded conductor assembly comprising the steps of
a. coating a first conductor and a second conductor with an insulating material thus forming a coated conductor assembly, wherein
i. said insulating material has a resistivity of from about 1×109 to about 1×1013 ohm-centimeter;
ii. said first conductor and said second conductor each have a resistivity of from about 1 to about 100 microohm-centimeters;
b. dispose an insulating matrix between said first conductor and second conductor of said coated conductor assembly to form an insulated conductor assembly, wherein said insulating matrix has a resistivity of from about 1×109 to about 1×1013 ohm-centimeter; and
c. coating said insulated conductor assembly with an insulation shield such that said insulation shield is disposed around said conductor wherein said insulation shield is comprised of said insulating material and electrically insulating particles, thus forming an electrically insulated conductor assembly, wherein
1. at least about 90 weight percent of said electrically insulating particles have a maximum dimension of less than about 100 nanometers;
2. said insulation shield has a saturation magnetization at 25 degrees Centigrade of at least about 2,000 Gauss;
3. said insulation shield has a resistivity of from about 1×109 to about 1×1013 ohm-centimeter;
42. The process for producing a magnetically shielded conductor assembly as recited in claim 41, further comprising the step of heating said insulated conductor assembly to a temperature of from about 200 degrees to about 600 degrees Centigrade for from about 1 minute to about 10 minutes so as to bond said insulating material to said first conductor and said second conductor.
43. The process for producing a magnetically shielded conductor assembly as recited in claim 42, further comprising the step of cooling said insulated conductor assembly to a temperature of from about 30 degrees to about 100 degrees Centigrade over a period of from about 3 minutes to about 15 minutes.
44. The process for producing a magnetically shielded conductor assembly as recited in claim 43, further comprising the step of heating said electrically insulated conductor assembly to a temperature of from about 200 degrees to about 600 degrees Centigrade for from about 1 to about 10 minutes so as to bond said electrically insulating particles to said magnetically shielded conductor assembly.
US11/085,415 2002-01-22 2005-03-21 Magnetically shielded conductor Abandoned US20050182471A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/085,415 US20050182471A1 (en) 2002-01-22 2005-03-21 Magnetically shielded conductor

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/054,407 US6506972B1 (en) 2002-01-22 2002-01-22 Magnetically shielded conductor
US10/229,183 US6876886B1 (en) 2002-01-22 2002-08-26 Magnetically shielded conductor
US11/085,415 US20050182471A1 (en) 2002-01-22 2005-03-21 Magnetically shielded conductor

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/229,183 Continuation US6876886B1 (en) 2002-01-22 2002-08-26 Magnetically shielded conductor

Publications (1)

Publication Number Publication Date
US20050182471A1 true US20050182471A1 (en) 2005-08-18

Family

ID=21990858

Family Applications (5)

Application Number Title Priority Date Filing Date
US10/054,407 Expired - Fee Related US6506972B1 (en) 2002-01-09 2002-01-22 Magnetically shielded conductor
US10/090,553 Expired - Fee Related US6930242B1 (en) 2002-01-22 2002-03-04 Magnetically shielded conductor
US10/229,183 Expired - Fee Related US6876886B1 (en) 2002-01-22 2002-08-26 Magnetically shielded conductor
US10/260,247 Expired - Fee Related US6673999B1 (en) 2002-01-22 2002-09-30 Magnetically shielded assembly
US11/085,415 Abandoned US20050182471A1 (en) 2002-01-22 2005-03-21 Magnetically shielded conductor

Family Applications Before (4)

Application Number Title Priority Date Filing Date
US10/054,407 Expired - Fee Related US6506972B1 (en) 2002-01-09 2002-01-22 Magnetically shielded conductor
US10/090,553 Expired - Fee Related US6930242B1 (en) 2002-01-22 2002-03-04 Magnetically shielded conductor
US10/229,183 Expired - Fee Related US6876886B1 (en) 2002-01-22 2002-08-26 Magnetically shielded conductor
US10/260,247 Expired - Fee Related US6673999B1 (en) 2002-01-22 2002-09-30 Magnetically shielded assembly

Country Status (1)

Country Link
US (5) US6506972B1 (en)

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050222657A1 (en) * 2004-03-30 2005-10-06 Wahlstrand Carl D MRI-safe implantable lead
US20090149933A1 (en) * 2007-12-06 2009-06-11 Cardiac Pacemakers, Inc. Implantable lead having a variable coil conductor pitch
US20100234929A1 (en) * 2009-03-12 2010-09-16 Torsten Scheuermann Thin profile conductor assembly for medical device leads
US7844343B2 (en) 2004-03-30 2010-11-30 Medtronic, Inc. MRI-safe implantable medical device
US7853332B2 (en) 2005-04-29 2010-12-14 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US7877150B2 (en) 2004-03-30 2011-01-25 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US8027736B2 (en) 2005-04-29 2011-09-27 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US8280526B2 (en) 2005-02-01 2012-10-02 Medtronic, Inc. Extensible implantable medical lead
US8483842B2 (en) 2007-04-25 2013-07-09 Medtronic, Inc. Lead or lead extension having a conductive body and conductive body contact
US8666512B2 (en) 2011-11-04 2014-03-04 Cardiac Pacemakers, Inc. Implantable medical device lead including inner coil reverse-wound relative to shocking coil
US8666508B2 (en) 2008-02-06 2014-03-04 Cardiac Pacemakers, Inc. Lead with MRI compatible design features
US8670840B2 (en) 2006-11-30 2014-03-11 Cardiac Pacemakers, Inc. RF rejecting lead
US8676351B2 (en) 2009-12-31 2014-03-18 Cardiac Pacemakers, Inc. MRI conditionally safe lead with low-profile multi-layer conductor for longitudinal expansion
US8688236B2 (en) 2008-05-09 2014-04-01 Cardiac Pacemakers, Inc. Medical lead coil conductor with spacer element
US8744600B2 (en) 2009-06-26 2014-06-03 Cardiac Pacemakers, Inc. Medical device lead including a unifilar coil with improved torque transmission capacity and reduced MRI heating
US8798767B2 (en) 2009-12-31 2014-08-05 Cardiac Pacemakers, Inc. MRI conditionally safe lead with multi-layer conductor
US8825179B2 (en) 2012-04-20 2014-09-02 Cardiac Pacemakers, Inc. Implantable medical device lead including a unifilar coiled cable
US8825181B2 (en) 2010-08-30 2014-09-02 Cardiac Pacemakers, Inc. Lead conductor with pitch and torque control for MRI conditionally safe use
US8954168B2 (en) 2012-06-01 2015-02-10 Cardiac Pacemakers, Inc. Implantable device lead including a distal electrode assembly with a coiled component
US8958889B2 (en) 2012-08-31 2015-02-17 Cardiac Pacemakers, Inc. MRI compatible lead coil
US8983623B2 (en) 2012-10-18 2015-03-17 Cardiac Pacemakers, Inc. Inductive element for providing MRI compatibility in an implantable medical device lead
US8989840B2 (en) 2004-03-30 2015-03-24 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US9044593B2 (en) 2007-02-14 2015-06-02 Medtronic, Inc. Discontinuous conductive filler polymer-matrix composites for electromagnetic shielding
US9155877B2 (en) 2004-03-30 2015-10-13 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US9186499B2 (en) 2009-04-30 2015-11-17 Medtronic, Inc. Grounding of a shield within an implantable medical lead
US9254380B2 (en) 2009-10-19 2016-02-09 Cardiac Pacemakers, Inc. MRI compatible tachycardia lead
US9463317B2 (en) 2012-04-19 2016-10-11 Medtronic, Inc. Paired medical lead bodies with braided conductive shields having different physical parameter values
US9504821B2 (en) 2014-02-26 2016-11-29 Cardiac Pacemakers, Inc. Construction of an MRI-safe tachycardia lead
US9731119B2 (en) 2008-03-12 2017-08-15 Medtronic, Inc. System and method for implantable medical device lead shielding
US9750944B2 (en) 2009-12-30 2017-09-05 Cardiac Pacemakers, Inc. MRI-conditionally safe medical device lead
US9993638B2 (en) 2013-12-14 2018-06-12 Medtronic, Inc. Devices, systems and methods to reduce coupling of a shield and a conductor within an implantable medical lead
US10155111B2 (en) 2014-07-24 2018-12-18 Medtronic, Inc. Methods of shielding implantable medical leads and implantable medical lead extensions
US10279171B2 (en) 2014-07-23 2019-05-07 Medtronic, Inc. Methods of shielding implantable medical leads and implantable medical lead extensions
US10537730B2 (en) 2007-02-14 2020-01-21 Medtronic, Inc. Continuous conductive materials for electromagnetic shielding

Families Citing this family (205)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713297B2 (en) * 1998-04-11 2010-05-11 Boston Scientific Scimed, Inc. Drug-releasing stent with ceramic-containing layer
US8244370B2 (en) * 2001-04-13 2012-08-14 Greatbatch Ltd. Band stop filter employing a capacitor and an inductor tank circuit to enhance MRI compatibility of active medical devices
US20080229590A1 (en) * 2001-01-22 2008-09-25 Robert Garrett Roofmates shingle knife
US20070168006A1 (en) * 2001-02-20 2007-07-19 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US20070168005A1 (en) * 2001-02-20 2007-07-19 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US20050288750A1 (en) * 2003-08-25 2005-12-29 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US6829509B1 (en) * 2001-02-20 2004-12-07 Biophan Technologies, Inc. Electromagnetic interference immune tissue invasive system
US20050288753A1 (en) * 2003-08-25 2005-12-29 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US20050283167A1 (en) * 2003-08-25 2005-12-22 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US20050283214A1 (en) * 2003-08-25 2005-12-22 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US6949929B2 (en) * 2003-06-24 2005-09-27 Biophan Technologies, Inc. Magnetic resonance imaging interference immune device
US20070173911A1 (en) * 2001-02-20 2007-07-26 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
CA2482202C (en) 2001-04-13 2012-07-03 Surgi-Vision, Inc. Systems and methods for magnetic-resonance-guided interventional procedures
US9295828B2 (en) 2001-04-13 2016-03-29 Greatbatch Ltd. Self-resonant inductor wound portion of an implantable lead for enhanced MRI compatibility of active implantable medical devices
US7727221B2 (en) 2001-06-27 2010-06-01 Cardiac Pacemakers Inc. Method and device for electrochemical formation of therapeutic species in vivo
US7011647B2 (en) * 2001-07-13 2006-03-14 Scimed Life Systems, Inc. Introducer sheath
US7150737B2 (en) * 2001-07-13 2006-12-19 Sci/Med Life Systems, Inc. Methods and apparatuses for navigating the subarachnoid space
JP3833926B2 (en) * 2001-11-05 2006-10-18 日本電子株式会社 Linear member and method of manufacturing linear member
US6506972B1 (en) * 2002-01-22 2003-01-14 Nanoset, Llc Magnetically shielded conductor
US6768053B1 (en) * 2002-01-09 2004-07-27 Nanoset, Llc Optical fiber assembly
US6906256B1 (en) * 2002-01-22 2005-06-14 Nanoset, Llc Nanomagnetic shielding assembly
US20040225213A1 (en) * 2002-01-22 2004-11-11 Xingwu Wang Magnetic resonance imaging coated assembly
WO2003061755A2 (en) * 2002-01-22 2003-07-31 Nanoset, Llc Nanomagnetically shielded substrate
US7091412B2 (en) * 2002-03-04 2006-08-15 Nanoset, Llc Magnetically shielded assembly
US20050178584A1 (en) * 2002-01-22 2005-08-18 Xingwu Wang Coated stent and MR imaging thereof
US7162302B2 (en) * 2002-03-04 2007-01-09 Nanoset Llc Magnetically shielded assembly
US20050260331A1 (en) * 2002-01-22 2005-11-24 Xingwu Wang Process for coating a substrate
US20050247472A1 (en) * 2002-01-22 2005-11-10 Helfer Jeffrey L Magnetically shielded conductor
US6844492B1 (en) * 2002-01-22 2005-01-18 Nanoset, Llc Magnetically shielded conductor
US20040210289A1 (en) * 2002-03-04 2004-10-21 Xingwu Wang Novel nanomagnetic particles
US7127294B1 (en) * 2002-12-18 2006-10-24 Nanoset Llc Magnetically shielded assembly
US8396568B2 (en) * 2002-04-11 2013-03-12 Medtronic, Inc. Medical electrical lead body designs incorporating energy dissipating shunt
JP4614281B2 (en) * 2002-12-16 2011-01-19 ジーイー・ヘルスケア・アクスイェ・セルスカプ Magnetic resonance imaging method and compound used in the method
US20040199069A1 (en) * 2003-04-02 2004-10-07 Connelly Patrick R. Device and method for preventing magnetic resonance imaging induced damage
US20050240100A1 (en) * 2003-04-08 2005-10-27 Xingwu Wang MRI imageable medical device
US20050155779A1 (en) * 2003-04-08 2005-07-21 Xingwu Wang Coated substrate assembly
US20070010702A1 (en) * 2003-04-08 2007-01-11 Xingwu Wang Medical device with low magnetic susceptibility
US20050261763A1 (en) * 2003-04-08 2005-11-24 Xingwu Wang Medical device
US20050149002A1 (en) * 2003-04-08 2005-07-07 Xingwu Wang Markers for visualizing interventional medical devices
US20050119725A1 (en) * 2003-04-08 2005-06-02 Xingwu Wang Energetically controlled delivery of biologically active material from an implanted medical device
US20040254419A1 (en) * 2003-04-08 2004-12-16 Xingwu Wang Therapeutic assembly
US20060102871A1 (en) * 2003-04-08 2006-05-18 Xingwu Wang Novel composition
US20050244337A1 (en) * 2003-04-08 2005-11-03 Xingwu Wang Medical device with a marker
US20050278020A1 (en) * 2003-04-08 2005-12-15 Xingwu Wang Medical device
US20050079132A1 (en) * 2003-04-08 2005-04-14 Xingwu Wang Medical device with low magnetic susceptibility
US20050025797A1 (en) * 2003-04-08 2005-02-03 Xingwu Wang Medical device with low magnetic susceptibility
US20050149169A1 (en) * 2003-04-08 2005-07-07 Xingwu Wang Implantable medical device
US7839146B2 (en) * 2003-06-24 2010-11-23 Medtronic, Inc. Magnetic resonance imaging interference immune device
US7388378B2 (en) * 2003-06-24 2008-06-17 Medtronic, Inc. Magnetic resonance imaging interference immune device
US20050050042A1 (en) * 2003-08-20 2005-03-03 Marvin Elder Natural language database querying
US20050288754A1 (en) * 2003-08-25 2005-12-29 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US20050288756A1 (en) * 2003-08-25 2005-12-29 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US8868212B2 (en) * 2003-08-25 2014-10-21 Medtronic, Inc. Medical device with an electrically conductive anti-antenna member
US20050288755A1 (en) * 2003-08-25 2005-12-29 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US20050288751A1 (en) * 2003-08-25 2005-12-29 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US20050288752A1 (en) * 2003-08-25 2005-12-29 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US20050283213A1 (en) * 2003-08-25 2005-12-22 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US7344559B2 (en) * 2003-08-25 2008-03-18 Biophan Technologies, Inc. Electromagnetic radiation transparent device and method of making thereof
US20050065587A1 (en) * 2003-09-24 2005-03-24 Mark Gryzwa Implantable lead with magnetic jacket
US20050070972A1 (en) * 2003-09-26 2005-03-31 Wahlstrand Carl D. Energy shunt for producing an MRI-safe implantable medical device
EP1522266A1 (en) * 2003-10-06 2005-04-13 Stryker Trauma SA External fixation elements
JP2005128771A (en) * 2003-10-23 2005-05-19 Fujitsu Ltd Data file system, data access server, and data access program
US20070027532A1 (en) * 2003-12-22 2007-02-01 Xingwu Wang Medical device
US7765005B2 (en) * 2004-02-12 2010-07-27 Greatbatch Ltd. Apparatus and process for reducing the susceptability of active implantable medical devices to medical procedures such as magnetic resonance imaging
US7174219B2 (en) * 2004-03-30 2007-02-06 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
US7758892B1 (en) * 2004-05-20 2010-07-20 Boston Scientific Scimed, Inc. Medical devices having multiple layers
FR2873324B1 (en) * 2004-07-22 2006-10-27 Bic Sa Soc LIQUID SUPPLY UNIT FOR A LIQUID PROJECTION INSTRUMENT AND A LIQUID PROJECTION INSTRUMENT COMPRISING SUCH A LIQUID SUPPLY
WO2006023700A2 (en) * 2004-08-20 2006-03-02 Biophan Technologies, Inc. Magnetic resonance imaging interference immune device
US20060118758A1 (en) * 2004-09-15 2006-06-08 Xingwu Wang Material to enable magnetic resonance imaging of implantable medical devices
DE102005045071A1 (en) * 2005-09-21 2007-04-12 Siemens Ag Catheter device with a position sensor system for the treatment of a partial and / or complete vascular occlusion under image monitoring
US20060127443A1 (en) * 2004-12-09 2006-06-15 Helmus Michael N Medical devices having vapor deposited nanoporous coatings for controlled therapeutic agent delivery
US8014867B2 (en) * 2004-12-17 2011-09-06 Cardiac Pacemakers, Inc. MRI operation modes for implantable medical devices
US7493167B2 (en) * 2005-03-22 2009-02-17 Greatbatch-Sierra, Inc. Magnetically shielded AIMD housing with window for magnetically actuated switch
US20070100231A1 (en) * 2005-05-19 2007-05-03 Biophan Technologies, Inc. Electromagnetic resonant circuit sleeve for implantable medical device
US7551967B1 (en) 2005-05-19 2009-06-23 Pacesetter, Inc. Implantable medical leads and devices having carbon nanotube-based anti-electrostatic coatings and methods for making such leads and devices
WO2006133365A2 (en) * 2005-06-08 2006-12-14 Nanoset, Llc Medical device
DE102005029270B4 (en) * 2005-06-23 2009-07-30 Siemens Ag Catheter, catheter device and diagnostic imaging device
US20070038176A1 (en) * 2005-07-05 2007-02-15 Jan Weber Medical devices with machined layers for controlled communications with underlying regions
DE102005032755B4 (en) * 2005-07-13 2014-09-04 Siemens Aktiengesellschaft System for performing and monitoring minimally invasive procedures
DE102005045362B4 (en) * 2005-09-22 2012-03-22 Siemens Ag Device for determining the position of a medical instrument, associated imaging examination device and associated method
DE102005045373A1 (en) * 2005-09-22 2007-04-05 Siemens Ag catheter device
DE102005050344A1 (en) 2005-10-20 2007-05-03 Siemens Ag Cryocatheter for medical investigation and treatment equipment for e.g. diagnosis and treatment of heart infarcts, has image capture device that maps region of vessel around balloon arranged near catheter tip
US7917213B2 (en) * 2005-11-04 2011-03-29 Kenergy, Inc. MRI compatible implanted electronic medical lead
DE102005059262B4 (en) * 2005-12-12 2008-02-07 Siemens Ag catheter device
US8840660B2 (en) * 2006-01-05 2014-09-23 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US8089029B2 (en) 2006-02-01 2012-01-03 Boston Scientific Scimed, Inc. Bioabsorbable metal medical device and method of manufacture
CA2643280C (en) * 2006-02-24 2014-05-27 American Bank Note Holographics, Inc. Method of reducing electro-static discharge (esd) from conductors on insulators
US20070239256A1 (en) * 2006-03-22 2007-10-11 Jan Weber Medical devices having electrical circuits with multilayer regions
US20070224244A1 (en) * 2006-03-22 2007-09-27 Jan Weber Corrosion resistant coatings for biodegradable metallic implants
US20070224235A1 (en) * 2006-03-24 2007-09-27 Barron Tenney Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8187620B2 (en) * 2006-03-27 2012-05-29 Boston Scientific Scimed, Inc. Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
DE102006015013B4 (en) * 2006-03-31 2010-06-02 Siemens Ag Implantable pacemaker
US8048150B2 (en) * 2006-04-12 2011-11-01 Boston Scientific Scimed, Inc. Endoprosthesis having a fiber meshwork disposed thereon
US20070264303A1 (en) * 2006-05-12 2007-11-15 Liliana Atanasoska Coating for medical devices comprising an inorganic or ceramic oxide and a therapeutic agent
US8815275B2 (en) 2006-06-28 2014-08-26 Boston Scientific Scimed, Inc. Coatings for medical devices comprising a therapeutic agent and a metallic material
JP2009542359A (en) * 2006-06-29 2009-12-03 ボストン サイエンティフィック リミテッド Medical device with selective covering
CA2658103A1 (en) * 2006-07-18 2008-01-24 American Bank Note Holographics, Inc. Holographic magnetic stripe demetalization security
US8049489B2 (en) * 2006-07-26 2011-11-01 Cardiac Pacemakers, Inc. Systems and methods for sensing external magnetic fields in implantable medical devices
US8052743B2 (en) 2006-08-02 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis with three-dimensional disintegration control
DE102006040936A1 (en) * 2006-08-31 2008-03-13 Siemens Ag Catheter for removing tissue from a hollow organ
EP2068757B1 (en) 2006-09-14 2011-05-11 Boston Scientific Limited Medical devices with drug-eluting coating
EP2081616B1 (en) * 2006-09-15 2017-11-01 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
EP2068782B1 (en) 2006-09-15 2011-07-27 Boston Scientific Limited Bioerodible endoprostheses
JP2010503491A (en) 2006-09-15 2010-02-04 ボストン サイエンティフィック リミテッド Bioerodible endoprosthesis with biologically stable inorganic layers
CA2663220A1 (en) * 2006-09-15 2008-03-20 Boston Scientific Limited Medical devices and methods of making the same
WO2008036457A2 (en) * 2006-09-18 2008-03-27 Boston Scientific Limited Controlling biodegradation of a medical instrument
US8002821B2 (en) * 2006-09-18 2011-08-23 Boston Scientific Scimed, Inc. Bioerodible metallic ENDOPROSTHESES
WO2008045184A1 (en) * 2006-10-05 2008-04-17 Boston Scientific Limited Polymer-free coatings for medical devices formed by plasma electrolytic deposition
US7981150B2 (en) 2006-11-09 2011-07-19 Boston Scientific Scimed, Inc. Endoprosthesis with coatings
US8768486B2 (en) * 2006-12-11 2014-07-01 Medtronic, Inc. Medical leads with frequency independent magnetic resonance imaging protection
US8502684B2 (en) 2006-12-22 2013-08-06 Geoffrey J. Bunza Sensors and systems for detecting environmental conditions or changes
US7812731B2 (en) * 2006-12-22 2010-10-12 Vigilan, Incorporated Sensors and systems for detecting environmental conditions or changes
DE102006061178A1 (en) * 2006-12-22 2008-06-26 Siemens Ag Medical system for carrying out and monitoring a minimal invasive intrusion, especially for treating electro-physiological diseases, has X-ray equipment and a control/evaluation unit
DE602007010669D1 (en) 2006-12-28 2010-12-30 Boston Scient Ltd HREN FOR THIS
US8070797B2 (en) 2007-03-01 2011-12-06 Boston Scientific Scimed, Inc. Medical device with a porous surface for delivery of a therapeutic agent
US8431149B2 (en) 2007-03-01 2013-04-30 Boston Scientific Scimed, Inc. Coated medical devices for abluminal drug delivery
US8067054B2 (en) 2007-04-05 2011-11-29 Boston Scientific Scimed, Inc. Stents with ceramic drug reservoir layer and methods of making and using the same
US7976915B2 (en) * 2007-05-23 2011-07-12 Boston Scientific Scimed, Inc. Endoprosthesis with select ceramic morphology
US8002823B2 (en) * 2007-07-11 2011-08-23 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7942926B2 (en) 2007-07-11 2011-05-17 Boston Scientific Scimed, Inc. Endoprosthesis coating
JP2010533563A (en) 2007-07-19 2010-10-28 ボストン サイエンティフィック リミテッド Endoprosthesis with adsorption inhibiting surface
US7931683B2 (en) 2007-07-27 2011-04-26 Boston Scientific Scimed, Inc. Articles having ceramic coated surfaces
US8815273B2 (en) * 2007-07-27 2014-08-26 Boston Scientific Scimed, Inc. Drug eluting medical devices having porous layers
US8221822B2 (en) * 2007-07-31 2012-07-17 Boston Scientific Scimed, Inc. Medical device coating by laser cladding
JP2010535541A (en) * 2007-08-03 2010-11-25 ボストン サイエンティフィック リミテッド Coating for medical devices with large surface area
US8052745B2 (en) * 2007-09-13 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis
US8029554B2 (en) * 2007-11-02 2011-10-04 Boston Scientific Scimed, Inc. Stent with embedded material
US7938855B2 (en) 2007-11-02 2011-05-10 Boston Scientific Scimed, Inc. Deformable underlayer for stent
US20090118813A1 (en) * 2007-11-02 2009-05-07 Torsten Scheuermann Nano-patterned implant surfaces
US8216632B2 (en) 2007-11-02 2012-07-10 Boston Scientific Scimed, Inc. Endoprosthesis coating
US20090118809A1 (en) * 2007-11-02 2009-05-07 Torsten Scheuermann Endoprosthesis with porous reservoir and non-polymer diffusion layer
US20090143855A1 (en) * 2007-11-29 2009-06-04 Boston Scientific Scimed, Inc. Medical Device Including Drug-Loaded Fibers
US8032228B2 (en) 2007-12-06 2011-10-04 Cardiac Pacemakers, Inc. Method and apparatus for disconnecting the tip electrode during MRI
US8086321B2 (en) 2007-12-06 2011-12-27 Cardiac Pacemakers, Inc. Selectively connecting the tip electrode during therapy for MRI shielding
US8275464B2 (en) 2007-12-06 2012-09-25 Cardiac Pacemakers, Inc. Leads with high surface resistance
EP2224995B1 (en) * 2007-12-06 2015-11-25 Cardiac Pacemakers, Inc. Implantable lead with shielding
US9233240B2 (en) 2007-12-12 2016-01-12 Pacesetter, Inc. Systems and methods for determining inductance and capacitance values for use with LC filters within implantable medical device leads to reduce lead heating during MRI
US20100008970A1 (en) * 2007-12-14 2010-01-14 Boston Scientific Scimed, Inc. Drug-Eluting Endoprosthesis
US8311637B2 (en) 2008-02-11 2012-11-13 Cardiac Pacemakers, Inc. Magnetic core flux canceling of ferrites in MRI
US8160717B2 (en) 2008-02-19 2012-04-17 Cardiac Pacemakers, Inc. Model reference identification and cancellation of magnetically-induced voltages in a gradient magnetic field
US9108066B2 (en) 2008-03-20 2015-08-18 Greatbatch Ltd. Low impedance oxide resistant grounded capacitor for an AIMD
US10080889B2 (en) 2009-03-19 2018-09-25 Greatbatch Ltd. Low inductance and low resistance hermetically sealed filtered feedthrough for an AIMD
US8920491B2 (en) 2008-04-22 2014-12-30 Boston Scientific Scimed, Inc. Medical devices having a coating of inorganic material
US8932346B2 (en) 2008-04-24 2015-01-13 Boston Scientific Scimed, Inc. Medical devices having inorganic particle layers
US20090281592A1 (en) * 2008-05-08 2009-11-12 Pacesetter, Inc. Shaft-mounted rf filtering elements for implantable medical device lead to reduce lead heating during mri
US7998192B2 (en) * 2008-05-09 2011-08-16 Boston Scientific Scimed, Inc. Endoprostheses
US9025598B1 (en) 2012-03-22 2015-05-05 Nuax, Inc. Cable/guidewire/interconnects communication apparatus and methods
US9242100B2 (en) 2012-08-07 2016-01-26 Nuax, Inc. Optical fiber-fine wire lead for electrostimulation and sensing
US9193313B2 (en) 2012-03-22 2015-11-24 Nuax, Inc. Methods and apparatuses involving flexible cable/guidewire/interconnects
US8692117B2 (en) 2008-05-28 2014-04-08 Cardia Access, Inc. Durable fine wire electrical conductor suitable for extreme environment applications
US9513443B2 (en) 2008-05-28 2016-12-06 John Lawrence Erb Optical fiber-fine wire conductor and connectors
US8236046B2 (en) 2008-06-10 2012-08-07 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US8449603B2 (en) 2008-06-18 2013-05-28 Boston Scientific Scimed, Inc. Endoprosthesis coating
US20100004733A1 (en) * 2008-07-02 2010-01-07 Boston Scientific Scimed, Inc. Implants Including Fractal Structures
US7985252B2 (en) * 2008-07-30 2011-07-26 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US20100036466A1 (en) * 2008-08-11 2010-02-11 Pacesetter, Inc. Lead construction with composite material shield layer
US8571661B2 (en) * 2008-10-02 2013-10-29 Cardiac Pacemakers, Inc. Implantable medical device responsive to MRI induced capture threshold changes
US8382824B2 (en) * 2008-10-03 2013-02-26 Boston Scientific Scimed, Inc. Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
US20110015713A1 (en) * 2008-10-23 2011-01-20 Pacesetter, Inc. Systems and methods for reducing lead heating and the risks of mri-induced stimulation
US20100106227A1 (en) * 2008-10-23 2010-04-29 Pacesetter, Inc. Systems and Methods for Disconnecting Electrodes of Leads of Implantable Medical Devices During an MRI to Reduce Lead Heating
US8301249B2 (en) * 2008-10-23 2012-10-30 Pacesetter, Inc. Systems and methods for exploiting the tip or ring conductor of an implantable medical device lead during an MRI to reduce lead heating and the risks of MRI-induced stimulation
US20100138192A1 (en) * 2008-12-01 2010-06-03 Pacesetter, Inc. Systems and Methods for Selecting Components for Use in RF Filters Within Implantable Medical Device Leads Based on Inductance, Parasitic Capacitance and Parasitic Resistance
US8644951B1 (en) 2009-12-02 2014-02-04 University Of Central Florida Research Foundation, Inc. Medical devices having MRI compatible metal alloys
US8231980B2 (en) * 2008-12-03 2012-07-31 Boston Scientific Scimed, Inc. Medical implants including iridium oxide
WO2010078552A1 (en) * 2009-01-05 2010-07-08 Kenergy, Inc. Mri compatible electrical lead for an implantable electronic medical device
JP5389947B2 (en) 2009-02-19 2014-01-15 カーディアック ペースメイカーズ, インコーポレイテッド System for providing arrhythmia therapy in an MRI environment
WO2010101901A2 (en) * 2009-03-02 2010-09-10 Boston Scientific Scimed, Inc. Self-buffering medical implants
US8071156B2 (en) * 2009-03-04 2011-12-06 Boston Scientific Scimed, Inc. Endoprostheses
DE112010001330T5 (en) * 2009-03-26 2012-02-16 Kenergy Inc. MRI-compatible implantable connection electrode interface
US8478423B2 (en) * 2009-04-07 2013-07-02 Boston Scientific Neuromodulation Corporation Insulator layers for leads of implantable electric stimulation systems and methods of making and using
US20100274352A1 (en) * 2009-04-24 2010-10-28 Boston Scientific Scrimed, Inc. Endoprosthesis with Selective Drug Coatings
US8287937B2 (en) * 2009-04-24 2012-10-16 Boston Scientific Scimed, Inc. Endoprosthese
CN102326202A (en) * 2009-06-30 2012-01-18 富士通先端科技株式会社 Magnetic card reader
US20110022158A1 (en) * 2009-07-22 2011-01-27 Boston Scientific Scimed, Inc. Bioerodible Medical Implants
US20110034983A1 (en) * 2009-08-07 2011-02-10 Pacesetter, Inc. Implantable medical device lead incorporating a conductive sheath surrounding insulated coils to reduce lead heating during mri
US8170687B2 (en) * 2009-08-07 2012-05-01 Pacesetter, Inc. Implantable medical device lead incorporating insulated coils formed as inductive bandstop filters to reduce lead heating during MRI
US8406897B2 (en) * 2009-08-19 2013-03-26 Boston Scientific Neuromodulation Corporation Systems and methods for disposing one or more layers of material between lead conductor segments of electrical stimulation systems
WO2011071597A1 (en) 2009-12-08 2011-06-16 Cardiac Pacemakers, Inc. Implantable medical device with automatic tachycardia detection and control in mri environments
US20110198118A1 (en) * 2010-02-17 2011-08-18 Ta Ya Electric Wire & Cable Co., Ltd. Magnet wire
US8668732B2 (en) * 2010-03-23 2014-03-11 Boston Scientific Scimed, Inc. Surface treated bioerodible metal endoprostheses
US8426734B2 (en) * 2010-06-28 2013-04-23 Ametek, Inc. Low noise ECG cable and electrical assembly
US8834657B2 (en) 2010-08-20 2014-09-16 Kenergy, Inc. Method of manufacturing an mri compatible conductive lead body
CN103282280B (en) 2010-10-27 2016-02-10 洲际大品牌有限责任公司 The accommodating packaging of the closeable product of magnetic
WO2012067713A1 (en) * 2010-11-18 2012-05-24 Cardiac Pacemakers, Inc. Insulative structure for mri compatible leads
US11198014B2 (en) 2011-03-01 2021-12-14 Greatbatch Ltd. Hermetically sealed filtered feedthrough assembly having a capacitor with an oxide resistant electrical connection to an active implantable medical device housing
US10350421B2 (en) 2013-06-30 2019-07-16 Greatbatch Ltd. Metallurgically bonded gold pocket pad for grounding an EMI filter to a hermetic terminal for an active implantable medical device
US10596369B2 (en) 2011-03-01 2020-03-24 Greatbatch Ltd. Low equivalent series resistance RF filter for an active implantable medical device
US9427596B2 (en) 2013-01-16 2016-08-30 Greatbatch Ltd. Low impedance oxide resistant grounded capacitor for an AIMD
US9931514B2 (en) 2013-06-30 2018-04-03 Greatbatch Ltd. Low impedance oxide resistant grounded capacitor for an AIMD
US10272252B2 (en) 2016-11-08 2019-04-30 Greatbatch Ltd. Hermetic terminal for an AIMD having a composite brazed conductive lead
CN103717130B (en) * 2011-05-20 2016-09-07 佛罗里达中央大学研究基金会 For finishing to the response of electromagnetic field through surface modified material
USRE46699E1 (en) 2013-01-16 2018-02-06 Greatbatch Ltd. Low impedance oxide resistant grounded capacitor for an AIMD
AU2014315377B2 (en) * 2013-09-06 2016-11-10 Boston Scientific Neuromodulation Corporation Systems and methods for reducing electromagnetic field-induced heating from an implantable pulse generator
EP3104933A1 (en) 2014-02-11 2016-12-21 Cardiac Pacemakers, Inc. Rf shield for an implantable lead
US9782581B2 (en) 2014-06-27 2017-10-10 Boston Scientific Neuromodulation Corporation Methods and systems for electrical stimulation including a shielded sheath
US9782582B2 (en) 2015-03-27 2017-10-10 Boston Scientific Neuromodulation Corporation Systems and methods for making and using electrical stimulation systems to reduce RF-induced tissue heating
JP2016197510A (en) * 2015-04-02 2016-11-24 日立金属株式会社 Magnetic shield element wire, method for producing the same, and magnetic shield braid sleeve and magnetic shield cable using the same
WO2016176645A1 (en) 2015-04-30 2016-11-03 Boston Scientific Neuromodulation Corporation Electrical stimulation leads and systems having a rf shield along at least the lead and methods of making and using
US9911559B2 (en) * 2016-01-29 2018-03-06 Microsoft Technology Licensing, Llc Magnetically aligned circuit
US9820418B1 (en) * 2016-03-24 2017-11-14 Jose Machado Electromagnetic contamination neutralization composition, device, and method
US10980979B2 (en) * 2016-05-13 2021-04-20 Becton, Dickinson And Company Magnetic shield for medical devices
US10249415B2 (en) 2017-01-06 2019-04-02 Greatbatch Ltd. Process for manufacturing a leadless feedthrough for an active implantable medical device
US10905888B2 (en) 2018-03-22 2021-02-02 Greatbatch Ltd. Electrical connection for an AIMD EMI filter utilizing an anisotropic conductive layer
US10912945B2 (en) 2018-03-22 2021-02-09 Greatbatch Ltd. Hermetic terminal for an active implantable medical device having a feedthrough capacitor partially overhanging a ferrule for high effective capacitance area

Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901741A (en) * 1973-08-23 1975-08-26 Gen Electric Permanent magnets of cobalt, samarium, gadolinium alloy
US4166263A (en) * 1977-10-03 1979-08-28 Hitachi Metals, Ltd. Magnetic core assembly for magnetizing columnar permanent magnet for use in electrostatic developing apparatus
US4168481A (en) * 1977-10-05 1979-09-18 Hitachi Metals, Ltd. Core assembly for magnetizing columnar permanent magnet for use in an electrostatic developing apparatus
US4169998A (en) * 1977-10-03 1979-10-02 Hitachi Metals, Ltd. Iron core assembly for magnetizing columnar permanent magnets for use in electrostatic developing apparatus
US4180600A (en) * 1975-10-23 1979-12-25 Nathan Feldstein Process using activated electroless plating catalysts
US4631613A (en) * 1984-04-16 1986-12-23 Eastman Kodak Company Thin film head having improved saturation magnetization
US4705613A (en) * 1984-04-16 1987-11-10 Eastman Kodak Company Sputtering method of making thin film head having improved saturation magnetization
US4705353A (en) * 1983-03-28 1987-11-10 Schlumberger Technology Corporation Optical fiber cable construction
US4778714A (en) * 1985-10-11 1988-10-18 Minnesota Mining And Manufacturing Company Nonabrasive magnetic recording tape
US4963291A (en) * 1988-06-13 1990-10-16 Bercaw Robert M Insulating electromagnetic shielding resin composition
US5213851A (en) * 1990-04-17 1993-05-25 Alfred University Process for preparing ferrite films by radio-frequency generated aerosol plasma deposition in atmosphere
US5260132A (en) * 1988-10-31 1993-11-09 Hitachi Maxell, Ltd. Acicular alloy magnetic powder
US5315365A (en) * 1992-06-17 1994-05-24 Laser Precision Corp. Macrobend splice loss tester for fiber optic splices with silicon gel cushion on optical coupling blocks
US5540959A (en) * 1995-02-21 1996-07-30 Howard J. Greenwald Process for preparing a coated substrate
US5543070A (en) * 1994-03-31 1996-08-06 Mitsubishi Materials Corporation Magnetic recording powder having low curie temperature and high saturation magnetization
US5667924A (en) * 1996-02-14 1997-09-16 Xerox Corporation Superparamagnetic image character recognition compositions and processes of making and using
US5889091A (en) * 1996-01-11 1999-03-30 Xerox Corporation Magnetic nanocompass compositions and processes for making and using
US5913005A (en) * 1997-01-29 1999-06-15 Sumitomo Electric Industries, Ltd. Single-mode optical fiber
US5946439A (en) * 1996-12-12 1999-08-31 Sumitomo Electric Industries, Ltd. Single-mode optical fiber
US6072930A (en) * 1998-11-04 2000-06-06 Syracuse University Method of fabricating a cylindrical optical fiber containing a particulate optically active film
US6506972B1 (en) * 2002-01-22 2003-01-14 Nanoset, Llc Magnetically shielded conductor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5452720A (en) * 1990-09-05 1995-09-26 Photoelectron Corporation Method for treating brain tumors
US6102885A (en) * 1996-08-08 2000-08-15 Bass; Lawrence S. Device for suction-assisted lipectomy and method of using same
US5927621A (en) * 1997-07-10 1999-07-27 Xerox Corporation Particle size reduction process
JPH1186641A (en) * 1997-09-10 1999-03-30 Hitachi Metals Ltd Cable
US6225565B1 (en) * 1999-06-07 2001-05-01 The Untied States Of America As Represented By The Secretary Of The Navy Flexible cable providing EMI shielding
US6768053B1 (en) * 2002-01-09 2004-07-27 Nanoset, Llc Optical fiber assembly
WO2003061755A2 (en) * 2002-01-22 2003-07-31 Nanoset, Llc Nanomagnetically shielded substrate

Patent Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901741A (en) * 1973-08-23 1975-08-26 Gen Electric Permanent magnets of cobalt, samarium, gadolinium alloy
US4180600A (en) * 1975-10-23 1979-12-25 Nathan Feldstein Process using activated electroless plating catalysts
US4166263A (en) * 1977-10-03 1979-08-28 Hitachi Metals, Ltd. Magnetic core assembly for magnetizing columnar permanent magnet for use in electrostatic developing apparatus
US4169998A (en) * 1977-10-03 1979-10-02 Hitachi Metals, Ltd. Iron core assembly for magnetizing columnar permanent magnets for use in electrostatic developing apparatus
US4168481A (en) * 1977-10-05 1979-09-18 Hitachi Metals, Ltd. Core assembly for magnetizing columnar permanent magnet for use in an electrostatic developing apparatus
US4705353A (en) * 1983-03-28 1987-11-10 Schlumberger Technology Corporation Optical fiber cable construction
US4631613A (en) * 1984-04-16 1986-12-23 Eastman Kodak Company Thin film head having improved saturation magnetization
US4705613A (en) * 1984-04-16 1987-11-10 Eastman Kodak Company Sputtering method of making thin film head having improved saturation magnetization
US4778714A (en) * 1985-10-11 1988-10-18 Minnesota Mining And Manufacturing Company Nonabrasive magnetic recording tape
US4963291A (en) * 1988-06-13 1990-10-16 Bercaw Robert M Insulating electromagnetic shielding resin composition
US5260132A (en) * 1988-10-31 1993-11-09 Hitachi Maxell, Ltd. Acicular alloy magnetic powder
US5213851A (en) * 1990-04-17 1993-05-25 Alfred University Process for preparing ferrite films by radio-frequency generated aerosol plasma deposition in atmosphere
US5315365A (en) * 1992-06-17 1994-05-24 Laser Precision Corp. Macrobend splice loss tester for fiber optic splices with silicon gel cushion on optical coupling blocks
US5543070A (en) * 1994-03-31 1996-08-06 Mitsubishi Materials Corporation Magnetic recording powder having low curie temperature and high saturation magnetization
US5540959A (en) * 1995-02-21 1996-07-30 Howard J. Greenwald Process for preparing a coated substrate
US5889091A (en) * 1996-01-11 1999-03-30 Xerox Corporation Magnetic nanocompass compositions and processes for making and using
US5667924A (en) * 1996-02-14 1997-09-16 Xerox Corporation Superparamagnetic image character recognition compositions and processes of making and using
US5946439A (en) * 1996-12-12 1999-08-31 Sumitomo Electric Industries, Ltd. Single-mode optical fiber
US5913005A (en) * 1997-01-29 1999-06-15 Sumitomo Electric Industries, Ltd. Single-mode optical fiber
US6072930A (en) * 1998-11-04 2000-06-06 Syracuse University Method of fabricating a cylindrical optical fiber containing a particulate optically active film
US6506972B1 (en) * 2002-01-22 2003-01-14 Nanoset, Llc Magnetically shielded conductor

Cited By (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050222657A1 (en) * 2004-03-30 2005-10-06 Wahlstrand Carl D MRI-safe implantable lead
US9155877B2 (en) 2004-03-30 2015-10-13 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US7844344B2 (en) 2004-03-30 2010-11-30 Medtronic, Inc. MRI-safe implantable lead
US7844343B2 (en) 2004-03-30 2010-11-30 Medtronic, Inc. MRI-safe implantable medical device
US7877150B2 (en) 2004-03-30 2011-01-25 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US9302101B2 (en) 2004-03-30 2016-04-05 Medtronic, Inc. MRI-safe implantable lead
US8989840B2 (en) 2004-03-30 2015-03-24 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US8280526B2 (en) 2005-02-01 2012-10-02 Medtronic, Inc. Extensible implantable medical lead
US7853332B2 (en) 2005-04-29 2010-12-14 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US8027736B2 (en) 2005-04-29 2011-09-27 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US8670840B2 (en) 2006-11-30 2014-03-11 Cardiac Pacemakers, Inc. RF rejecting lead
US10398893B2 (en) 2007-02-14 2019-09-03 Medtronic, Inc. Discontinuous conductive filler polymer-matrix composites for electromagnetic shielding
US10537730B2 (en) 2007-02-14 2020-01-21 Medtronic, Inc. Continuous conductive materials for electromagnetic shielding
US9044593B2 (en) 2007-02-14 2015-06-02 Medtronic, Inc. Discontinuous conductive filler polymer-matrix composites for electromagnetic shielding
US8483842B2 (en) 2007-04-25 2013-07-09 Medtronic, Inc. Lead or lead extension having a conductive body and conductive body contact
US9259572B2 (en) 2007-04-25 2016-02-16 Medtronic, Inc. Lead or lead extension having a conductive body and conductive body contact
US8731685B2 (en) * 2007-12-06 2014-05-20 Cardiac Pacemakers, Inc. Implantable lead having a variable coil conductor pitch
US20090149933A1 (en) * 2007-12-06 2009-06-11 Cardiac Pacemakers, Inc. Implantable lead having a variable coil conductor pitch
US8666508B2 (en) 2008-02-06 2014-03-04 Cardiac Pacemakers, Inc. Lead with MRI compatible design features
US9731119B2 (en) 2008-03-12 2017-08-15 Medtronic, Inc. System and method for implantable medical device lead shielding
US8688236B2 (en) 2008-05-09 2014-04-01 Cardiac Pacemakers, Inc. Medical lead coil conductor with spacer element
US9084883B2 (en) 2009-03-12 2015-07-21 Cardiac Pacemakers, Inc. Thin profile conductor assembly for medical device leads
US20100234929A1 (en) * 2009-03-12 2010-09-16 Torsten Scheuermann Thin profile conductor assembly for medical device leads
US9186499B2 (en) 2009-04-30 2015-11-17 Medtronic, Inc. Grounding of a shield within an implantable medical lead
US10086194B2 (en) 2009-04-30 2018-10-02 Medtronic, Inc. Termination of a shield within an implantable medical lead
US10035014B2 (en) 2009-04-30 2018-07-31 Medtronic, Inc. Steering an implantable medical lead via a rotational coupling to a stylet
US9629998B2 (en) 2009-04-30 2017-04-25 Medtronics, Inc. Establishing continuity between a shield within an implantable medical lead and a shield within an implantable lead extension
US9272136B2 (en) 2009-04-30 2016-03-01 Medtronic, Inc. Grounding of a shield within an implantable medical lead
US9452284B2 (en) 2009-04-30 2016-09-27 Medtronic, Inc. Termination of a shield within an implantable medical lead
US9205253B2 (en) 2009-04-30 2015-12-08 Medtronic, Inc. Shielding an implantable medical lead
US9216286B2 (en) 2009-04-30 2015-12-22 Medtronic, Inc. Shielded implantable medical lead with guarded termination
US9220893B2 (en) 2009-04-30 2015-12-29 Medtronic, Inc. Shielded implantable medical lead with reduced torsional stiffness
US8744600B2 (en) 2009-06-26 2014-06-03 Cardiac Pacemakers, Inc. Medical device lead including a unifilar coil with improved torque transmission capacity and reduced MRI heating
US9254380B2 (en) 2009-10-19 2016-02-09 Cardiac Pacemakers, Inc. MRI compatible tachycardia lead
US9750944B2 (en) 2009-12-30 2017-09-05 Cardiac Pacemakers, Inc. MRI-conditionally safe medical device lead
US9199077B2 (en) 2009-12-31 2015-12-01 Cardiac Pacemakers, Inc. MRI conditionally safe lead with multi-layer conductor
US8676351B2 (en) 2009-12-31 2014-03-18 Cardiac Pacemakers, Inc. MRI conditionally safe lead with low-profile multi-layer conductor for longitudinal expansion
US8798767B2 (en) 2009-12-31 2014-08-05 Cardiac Pacemakers, Inc. MRI conditionally safe lead with multi-layer conductor
US9050457B2 (en) 2009-12-31 2015-06-09 Cardiac Pacemakers, Inc. MRI conditionally safe lead with low-profile conductor for longitudinal expansion
US8825181B2 (en) 2010-08-30 2014-09-02 Cardiac Pacemakers, Inc. Lead conductor with pitch and torque control for MRI conditionally safe use
US8666512B2 (en) 2011-11-04 2014-03-04 Cardiac Pacemakers, Inc. Implantable medical device lead including inner coil reverse-wound relative to shocking coil
US9463317B2 (en) 2012-04-19 2016-10-11 Medtronic, Inc. Paired medical lead bodies with braided conductive shields having different physical parameter values
US8825179B2 (en) 2012-04-20 2014-09-02 Cardiac Pacemakers, Inc. Implantable medical device lead including a unifilar coiled cable
US8954168B2 (en) 2012-06-01 2015-02-10 Cardiac Pacemakers, Inc. Implantable device lead including a distal electrode assembly with a coiled component
US9333344B2 (en) 2012-06-01 2016-05-10 Cardiac Pacemakers, Inc. Implantable device lead including a distal electrode assembly with a coiled component
US8958889B2 (en) 2012-08-31 2015-02-17 Cardiac Pacemakers, Inc. MRI compatible lead coil
US9504822B2 (en) 2012-10-18 2016-11-29 Cardiac Pacemakers, Inc. Inductive element for providing MRI compatibility in an implantable medical device lead
US8983623B2 (en) 2012-10-18 2015-03-17 Cardiac Pacemakers, Inc. Inductive element for providing MRI compatibility in an implantable medical device lead
US9993638B2 (en) 2013-12-14 2018-06-12 Medtronic, Inc. Devices, systems and methods to reduce coupling of a shield and a conductor within an implantable medical lead
US9682231B2 (en) 2014-02-26 2017-06-20 Cardiac Pacemakers, Inc. Construction of an MRI-safe tachycardia lead
US9504821B2 (en) 2014-02-26 2016-11-29 Cardiac Pacemakers, Inc. Construction of an MRI-safe tachycardia lead
US10279171B2 (en) 2014-07-23 2019-05-07 Medtronic, Inc. Methods of shielding implantable medical leads and implantable medical lead extensions
US10155111B2 (en) 2014-07-24 2018-12-18 Medtronic, Inc. Methods of shielding implantable medical leads and implantable medical lead extensions

Also Published As

Publication number Publication date
US6506972B1 (en) 2003-01-14
US6930242B1 (en) 2005-08-16
US6876886B1 (en) 2005-04-05
US6673999B1 (en) 2004-01-06

Similar Documents

Publication Publication Date Title
US6876886B1 (en) Magnetically shielded conductor
US6906256B1 (en) Nanomagnetic shielding assembly
US6971391B1 (en) Protective assembly
US20050247472A1 (en) Magnetically shielded conductor
US6844492B1 (en) Magnetically shielded conductor
US7162302B2 (en) Magnetically shielded assembly
US6846985B2 (en) Magnetically shielded assembly
US7127294B1 (en) Magnetically shielded assembly
US6980865B1 (en) Implantable shielded medical device
US7091412B2 (en) Magnetically shielded assembly
US7473843B2 (en) Magnetic resonance imaging coated assembly
US6765144B1 (en) Magnetic resonance imaging coated assembly
US8788058B2 (en) Leads with high surface resistance
US5827186A (en) Method and PDT probe for minimizing CT and MRI image artifacts
US7493167B2 (en) Magnetically shielded AIMD housing with window for magnetically actuated switch
EP2125103B1 (en) Continuous conductive materials for electromagnetic shielding
WO2009076169A2 (en) Implantable lead with shielding
EP2520334A1 (en) Magnetic stimulation using plasma

Legal Events

Date Code Title Description
AS Assignment

Owner name: NANOSET, LLC, NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WANG, XINGWU;REEL/FRAME:016413/0373

Effective date: 20050311

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: BIOPHAN TECHNOLOGIES, INC., NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NANOSET, LLC;REEL/FRAME:020635/0205

Effective date: 20080215